Results 151 to 160 of about 18,188 (219)

Obligatory and accessory respiratory muscle structure, function and control in early and advanced disease in the mdx mouse model of Duchenne muscular dystrophy. [PDF]

J Physiol
Slyne AD, Burns DP, Wöller K, May A, Dowd R, Drummond SE, Jasionek G, O'Halloran KD.   +7 more
europepmc   +1 more source

Volitional exercise elicits physiological and molecular improvements in the severe D2.mdx mouse model of Duchenne muscular dystrophy. [PDF]

J Physiol
Mattina SR, Ng SY, Mikhail AI, Stouth DW, Jornacion CE, Rebalka IA, Hawke TJ, Ljubicic V.   +7 more
europepmc   +1 more source

Author Correction: Humanizing the mdx mouse model of DMD: the long and the short of it. [PDF]

NPJ Regen Med, 2020
Yucel N, Chang AC, Day JW, Rosenthal N, Blau HM.   +4 more
europepmc   +1 more source

Exploring the Therapeutic Potential of Ectoine in Duchenne Muscular Dystrophy: Comparison with Taurine, a Supplement with Known Beneficial Effects in the mdx Mouse. [PDF]

Int J Mol Sci, 2022
Merckx C, Zschüntzsch J, Meyer S, Raedt R, Verschuere H, Schmidt J, De Paepe B, De Bleecker JL.   +7 more
europepmc   +1 more source

Repurposed Nrf2 activator dimethyl fumarate rescues muscle inflammation and fibrosis in an aggravated mdx mouse model of Duchenne muscular dystrophy. [PDF]

Redox Biol
Kourakis S, Timpani CA, Bagaric RM, Qi B, Ali BA, Boyer R, Spiesberger G, Kandhari N, Yan X, Kuang J, Tulangekar A, de Haan JB, Deveson-Lucas D, Stupka N, Fischer D, Rybalka E.   +15 more
europepmc   +1 more source

Lipocalin 2 Influences Bone and Muscle Phenotype in the MDX Mouse Model of Duchenne Muscular Dystrophy. [PDF]

Int J Mol Sci, 2022
Ponzetti M, Ucci A, Maurizi A, Giacchi L, Teti A, Rucci N.   +5 more
europepmc   +1 more source

Pharmacology and macrophage modulation of HPGDS inhibitor PK007 demonstrate reduced disease severity in DMD-affected muscles of the mdx mouse model. [PDF]

Skelet Muscle
Yarlagadda S, Sheremeta CL, Cheung SW, Cuffe A, Grounds MD, Smythe ML, Noakes PG.   +6 more
europepmc   +1 more source

PPMO-based exon skipping therapy improves respiratory function in the <i>mdx</i> mouse model of Duchenne muscular dystrophy. [PDF]

Mol Ther Nucleic Acids
Biswas DD, Rodriguez MYH, El Haddad L, Hoffmann G, Copson E, Mayman S, Jose J, Lang S, Chen O, Dela Pena A, Levin E, Abdelbarr M, Slyne A, ElMallah MK.   +13 more
europepmc   +1 more source

Identification of suitable qPCR reference genes for the normalization of gene expression in the BL10-mdx and D2-mdx mouse models of Duchenne muscular dystrophy. [PDF]

PLoS One
Putker K, Schneider AF, Van De Vijver D, Hildyard J, Aartsma-Rus A, van Putten M.   +5 more
europepmc   +1 more source

The D2.mdx mouse as a preclinical model of the skeletal muscle pathology associated with Duchenne muscular dystrophy. [PDF]

Sci Rep, 2020
Hammers DW, Hart CC, Matheny MK, Wright LA, Armellini M, Barton ER, Sweeney HL.   +6 more
europepmc   +1 more source